A bipartisan group of U.S. senators wrote a letter to the Federal Trade Commission in January requesting an update on its ongoing investigation of pharmacy benefit managers.
"We support the FTC's issuance of a Section 6(b) order and conducting a timely study of PBMs' business practices," said the letter from Sen. Chuck Grassley, R-Iowa, Sen. Maria Cantwell, D-Wash., and 12 colleagues. "With the FTC's inquiry reaching its year-and-a-half mark, we urge the FTC to complete the study without delay. In the interim, we believe it is important to know the status of the study and therefore ask the FTC to issue a progress report."
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
